Added Benefits and User Satisfaction with a Low-Dose Oral Contraceptive Containing Drospirenone

@article{Bitzer2009AddedBA,
  title={Added Benefits and User Satisfaction with a Low-Dose Oral Contraceptive Containing Drospirenone},
  author={J. Bitzer and A. Paoletti},
  journal={Clinical Drug Investigation},
  year={2009},
  volume={29},
  pages={73-78}
}
The ethinylestradiol 20 μg/drospirenone 3 mg combined oral contraceptive (COC), administered in cycles of 21 days continuous use followed by a 7-day hormone-free interval (21/7) [Yasminelle®], has been proven to be an effective and well tolerated contraceptive with an acceptable bleeding pattern and good safety profile. In addition, the ethinylestradiol 20 μg/drospirenone 3 mg 21/7 COC prevents water-retention-related weight gain, and improves physical and emotional well-being, consistent with… Expand
View on Springer
ncbi.nlm.nih.gov
4 Citations
Highly Influential Citations
1
Background Citations
1
Methods Citations
1

4 Citations

Citation Type

Citation Type

Psychosexual well-being in women using oral contraceptives containing drospirenone.
Estetrol combined with drospirenone: an oral contraceptive with high acceptability, user satisfaction, well-being and favourable body weight control
Tailoring combination oral contraceptives to the individual woman.
Индивидуальный выбор гормонального контрацептивного средства

References

SHOWING 1-10 OF 31 REFERENCES
The acceptability of a novel oral contraceptive containing drospirenone and its effect on well-being.
Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone
  • J. Huber, J. Foidart, +5 authors R. Heithecker
  • Medicine
  • The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
  • 2000
Efficacy of a New Low-Dose Oral Contraceptive With Drospirenone in Premenstrual Dysphoric Disorder
A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel.
Effect of an oral contraceptive containing drospirenone and ethinylestradiol on general well-being and fluid-related symptoms
  • D. Apter, A. Borsos, +5 authors S. Kelly
  • Medicine
  • The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
  • 2003
Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 μg ethinylestradiol and 3 mg drospirenone
A new monophasic oral contraceptive containing drospirenone. Effect on premenstrual symptoms.
Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment.
Efficacy and Safety of a Low-Dose 21-Day Combined Oral Contraceptive Containing Ethinylestradiol 20μg and Drospirenone 3mg
Psychological effect of the oral contraceptive formulation containing 3 mg of drospirenone plus 30 microg of ethinyl estradiol.
...
1
2
3
4
...